3M makes multi-million investments
The US multinational technology group 3M is building a new production plant for dialysis membranes at its site in Wuppertal at a cost of over 36 million euros. The largest and most flexible 3M laboratory facility outside the US is being built in Hilden for around 11 million euros.
With its Wuppertal plant, 3M is regarded as one of the leading suppliers of membranes for medical and technical-industrial applications. Here the group produces filters for blood purification procedures, also known as dialysis. Using the new, automated system 3M can now produce dialysis membranes continuously and in high quality.
The investment represents a response to the continuously increasing demand for blood purification systems. Lifestyle diseases such as obesity, diabetes and renal failure are increasing worldwide, making this form of treatment increasingly necessary. The new production facility enables 3M to increase its production capacity by 50 percent. As recently as April, the company announced an investment of 25 million euros for refurbishments in Wuppertal.
The US company is making a further investment in Hilden, where a new laboratory facility is being built to supplement 3M's existing R&D facilities. At the new facility, the group will conduct research into new processes and products for, among others, the automotive and medical markets. For example, novel solvent-free adhesive tape and film products are to be developed that help to save resources and weight in, for example, automobile manufacturing.
"This investment will strengthen 3M in Germany and Hilden as a location. With the new laboratory plant, existing production processes can be improved and novel materials and methods can be developed for later production at the plants," explains Dr. Jürgen Klingen, Head of Corporate Research Materials & Process Laboratories in the DACH region.